ES2186911T3 - Compuestos nucleotidico de fosfonato. - Google Patents

Compuestos nucleotidico de fosfonato.

Info

Publication number
ES2186911T3
ES2186911T3 ES97934776T ES97934776T ES2186911T3 ES 2186911 T3 ES2186911 T3 ES 2186911T3 ES 97934776 T ES97934776 T ES 97934776T ES 97934776 T ES97934776 T ES 97934776T ES 2186911 T3 ES2186911 T3 ES 2186911T3
Authority
ES
Spain
Prior art keywords
similar
rent
group
replaced
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97934776T
Other languages
English (en)
Inventor
Masaru Ubasawa
Kouichi Sekiya
Hideaki Takashima
Naoko Ueda
Satoshi Yuasa
Naohiro Kamiya
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Chemical Corp
Original Assignee
Mitsubishi Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chemical Corp filed Critical Mitsubishi Chemical Corp
Application granted granted Critical
Publication of ES2186911T3 publication Critical patent/ES2186911T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
    • C07F9/65616—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings containing the ring system having three or more than three double bonds between ring members or between ring members and non-ring members, e.g. purine or analogs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA INVENCION SE REFIERE A UN COMPUESTO DE FOSFONATO DE NUCLEOTIDO, REPRESENTADO POR LA FORMULA (I): (DONDE R 1 ES UN GRUPO ALQUILO C 1 - C 6 O SIMILAR, R 2 ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO C 1 - C 4 SUSTITUIDO POR UNO O MAS ATOMOS DE HALOGENO O SIMILARES, R 3 ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO C 1 - C 4 SUSTITUIDO POR UNO O MAS ATOMOS DE HALOGENO O SIMILARES, R 4 ES UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO SUSTITUIDO POR UNO O MAS ATOMOS DE HALOGENO Y X ES UN ATOMO DE CARBONO O UN ATOMO DE NITROGENO). ASIMISMO SE INCLUYE UNA SAL, HIDRATO O SOLVATO DEL MISMO, ASI COMO UN MEDICAMENTO QUE LO CONTIENE. DICHO COMPUESTO ES UTIL COMO AGENTE ANTIVIRAL FRENTE AL VIRUS DE LA INMUNODEFICIENCIA HUMANA, AL DEL HERPEX SIMPLEX, AL DE LA HEPATITIS B O SIMILARES, Y COMO AGENTE ANTITUMORAL.
ES97934776T 1996-08-13 1997-08-12 Compuestos nucleotidico de fosfonato. Expired - Lifetime ES2186911T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21369196 1996-08-13

Publications (1)

Publication Number Publication Date
ES2186911T3 true ES2186911T3 (es) 2003-05-16

Family

ID=16643397

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97934776T Expired - Lifetime ES2186911T3 (es) 1996-08-13 1997-08-12 Compuestos nucleotidico de fosfonato.

Country Status (8)

Country Link
US (1) US6194398B1 (es)
EP (1) EP0919562B1 (es)
KR (1) KR20000029952A (es)
CN (1) CN1085673C (es)
CA (1) CA2263286A1 (es)
DE (1) DE69716924T2 (es)
ES (1) ES2186911T3 (es)
WO (1) WO1998006726A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003028737A1 (en) * 2001-08-30 2003-04-10 Mitsubishi Pharma Corporation Anti-viral agents and in-vitro method for the identification of candidates able to inhibit binding of polymerase to epsilon
AU2002343556A1 (en) * 2001-12-07 2003-06-23 Eli Lilly And Company Use of phosphonate nucleotide analogue for treating hepatitis b virus infections
AU2003231765B9 (en) 2002-04-26 2010-01-28 Gilead Sciences, Inc. Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds and the compounds as such
WO2004096287A2 (en) 2003-04-25 2004-11-11 Gilead Sciences, Inc. Inosine monophosphate dehydrogenase inhibitory phosphonate compounds
MXPA05011296A (es) 2003-04-25 2006-01-24 Gilead Sciences Inc Conjugados de fosfonato inhibidores de la cinasa.
US7470724B2 (en) 2003-04-25 2008-12-30 Gilead Sciences, Inc. Phosphonate compounds having immuno-modulatory activity
EP2359833A1 (en) * 2003-04-25 2011-08-24 Gilead Sciences, Inc. Antiviral phosphonate analogs
US7273716B2 (en) 2003-04-25 2007-09-25 Gilead Sciences, Inc. Methods and compositions for identifying therapeutic compounds with GS-7340 ester hydrolase
US7432261B2 (en) 2003-04-25 2008-10-07 Gilead Sciences, Inc. Anti-inflammatory phosphonate compounds
US7452901B2 (en) 2003-04-25 2008-11-18 Gilead Sciences, Inc. Anti-cancer phosphonate analogs
WO2005002626A2 (en) 2003-04-25 2005-01-13 Gilead Sciences, Inc. Therapeutic phosphonate compounds
US7300924B2 (en) 2003-04-25 2007-11-27 Gilead Sciences, Inc. Anti-infective phosphonate analogs
US7407965B2 (en) 2003-04-25 2008-08-05 Gilead Sciences, Inc. Phosphonate analogs for treating metabolic diseases
US7427624B2 (en) 2003-10-24 2008-09-23 Gilead Sciences, Inc. Purine nucleoside phosphorylase inhibitory phosphonate compounds
WO2005044308A1 (en) 2003-10-24 2005-05-19 Gilead Sciences, Inc. Phosphonate analogs of antimetabolites
WO2005063751A1 (en) 2003-12-22 2005-07-14 Gilead Sciences, Inc. 4’-substituted carbovir-and abacavir-derivatives as well as related compounds with hiv and hcv antiviral activity
ME03423B (me) 2004-07-27 2020-01-20 Gilead Sciences Inc Fosfonatni analozi jedinjenja hiv inhibitora
WO2007014491A1 (fr) * 2005-08-03 2007-02-08 Beijing Fu Kang Ren Bio-Pharm Tech.Co.Ltd. Phosphonates de nucléotides acycliques et leur utilisation dans des agents antiviraux
CA2720575A1 (en) 2008-01-15 2009-07-23 Nicholas L. Taro Method and apparatus for determining a deterioration of respiratory function
UA103329C2 (ru) 2008-07-08 2013-10-10 Гилиад Сайенсиз, Инк. Соли соединений-ингибиторов вич
ES2874774T3 (es) 2011-12-22 2021-11-05 Geron Corp Análogos de guanina como sustratos de telomerasa y afectores de la longitud de los telómeros
SI3661937T1 (sl) 2017-08-01 2021-11-30 Gilead Sciences, Inc. Kristalinične oblike etil((S)-((((2R,5R)-5-(6-amino-9H-purin-9-IL)-4- fluoro-2,5-dihidrofuran-2-IL)oksi)metil)(fenoksi)fosforil)-L-alaninata (GS-9131) za zdravljenje virusnih okužb
EP4182365A1 (en) 2020-07-17 2023-05-24 Dow Global Technologies LLC Hydrocarbyl-modified methylaluminoxane cocatalysts for constrained geometry procatalysts
US12606647B2 (en) 2020-07-17 2026-04-21 Dow Global Technologies Llc Hydrocarbyl-modified methylaluminoxane cocatalysts for bis-phenylphenoxy metal-ligand complexes

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0468119A1 (en) * 1990-07-24 1992-01-29 Merrell Dow Pharmaceuticals Inc. Novel carbocyclic analogs of certain nucleosides
JP3580377B2 (ja) * 1993-06-29 2004-10-20 三菱化学株式会社 ホスホナートヌクレオチドエステル誘導体
ATE199906T1 (de) 1993-06-29 2001-04-15 Mitsubishi Chem Corp Phosphonat-nukleotid ester-derivate
CA2195262C (en) * 1996-01-18 2005-08-09 Masaru Ubasawa Phosphonate nucleotide compounds

Also Published As

Publication number Publication date
CA2263286A1 (en) 1998-02-19
EP0919562A1 (en) 1999-06-02
WO1998006726A1 (en) 1998-02-19
KR20000029952A (ko) 2000-05-25
DE69716924T2 (de) 2003-03-20
CN1085673C (zh) 2002-05-29
EP0919562B1 (en) 2002-11-06
CN1232466A (zh) 1999-10-20
DE69716924D1 (de) 2002-12-12
US6194398B1 (en) 2001-02-27
EP0919562A4 (en) 1999-10-13

Similar Documents

Publication Publication Date Title
ES2186911T3 (es) Compuestos nucleotidico de fosfonato.
US5262383A (en) 3-aryl-4-hydroxy- DELTA 3-dihydrofuranone and 3-aryl-4-hydroxy- DELTA 3-dihydrothiophenone derivatives and pesticidal use
ES2104015T3 (es) Derivado del acido metoxiiminoacetico y fungicida agricola/horticola que lo contiene como ingrediente activo.
CY1105957T1 (el) Χρηση οιστρογονων ενωσεων σε συνδυασμο με ενωσεις προγεστογονου (progestogen) σε θepαπεια ορμονικης αντικαταστασης
MX174018B (es) Composiciones generadoras de gas que contienen nitrotriazolona
TR200003011T2 (tr) Yeni dihidropirimidinler.
NZ503910A (en) Alpha-aryl-N-alkylnitrones and pharmaceutical compositions containing the same
ES2157593T3 (es) Derivados de la adenosina heterociclicos sustituidos en n6.
BR9709427A (pt) Oxa ácidos e compostos relacionados para tratamento de condições da pele
ATE224909T1 (de) 1-(2-deoxy-2-fluoro-4-thio-beta-d- arabinofuranosyl)-cytosine
DE60112330D1 (en) Pyrazolopyridinderivate
DE60112200D1 (de) Verfahren zur Herstellung von Carbonyl- oder Hydroxy-Verbindungen
DE60125040D1 (de) Wässrige Harzzusammensetzung
ES2164366T3 (es) Derivados de la distamicina acriloil sustituidos, procedimiento de fabricacion asociado y su utilizacion como agentes antitumorales y antivirales.
ES2026669T3 (es) Procedimiento para la preparacion y el uso terapeutico de los beta-d-fenil tioxilosidos.
ES2183340T3 (es) Procedimiento para la preparcion de compuestos de 4-bromometil-bifenilo.
AR012878A1 (es) Un compuesto derivado de 5'-desoxicitidina, su uso, un proceso para fabricarlo, composiciones farmaceuticas que lo comprende, y un kit que comprende dicha composicion.
BR0108046A (pt) Compostos azol condensados e seu uso como agentes hipoglicêmicos
ATE161717T1 (de) Antivirale mittel
PE63696A1 (es) Compuesto quimico
BR9708418A (pt) Amino-e trifenil-s-triazinas hodroxissubstituídas como estabilizadores
ES2146643T3 (es) Fenilcarboxamida-isoxazoles y sus sales, su procedimiento de preparacion, su aplicacion como medicamentos y composiciones farmaceuticas que lo contienen.
BR0115996A (pt) Sulfamidotienopirimidinas
PE33796A1 (es) Compuesto ariltio
CO5021214A1 (es) Derivado del acido 2-metilpropionico y composicion farmaceutica que lo contiene